Compare Agilent Technologies Inc (A) vs Global X Robotics and Artificial Intelligence ETF (BOTZ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Global X Robotics and Artificial Intelligence ETF — how do they compare? Agilent Technologies Inc trades at $128.5 (market cap $37.04B), while Global X Robotics and Artificial Intelligence ETF trades at $35.9. The key difference: Agilent Technologies Inc pays a 0.78% dividend while Global X Robotics and Artificial Intelligence ETF pays none. Which is the better fit depends on your goals.
| A | BOTZ | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | — |
52-Week High | $157.20 | $41.63 |
52-Week Low | $110.24 | $31.99 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
BOTZ trades at $36.59, down 2.14% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF focuses on robotics and AI, benefiting from reshoring trends and AI's expansion into physical automation. Recent news highlights robotics as the next trillion-dollar AI theme, with strong media coverage positioning BOTZ as a key player in the humanoid robotics and industrial automation space.
Outlook remains positive due to structural growth in robotics and AI, though valuation metrics are unavailable. Risks include sector concentration and reliance on AI adoption pace. Analyst sentiment is generally favorable, with the ETF well-positioned for long-term automation trends but vulnerable to tech sector volatility and economic cycles.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Global X Robotics and Artificial Intelligence ETF
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that are involved in the development of robotics and/or artificial intelligence. The fund is non-diversified.
Read more on BOTZ →
